These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 29049963)

  • 1. Optimization of physicochemical properties for 4-anilinoquinazoline inhibitors of trypanosome proliferation.
    Woodring JL; Bachovchin KA; Brady KG; Gallerstein MF; Erath J; Tanghe S; Leed SE; Rodriguez A; Mensa-Wilmot K; Sciotti RJ; Pollastri MP
    Eur J Med Chem; 2017 Dec; 141():446-459. PubMed ID: 29049963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinase scaffold repurposing for neglected disease drug discovery: discovery of an efficacious, lapatinib-derived lead compound for trypanosomiasis.
    Patel G; Karver CE; Behera R; Guyett PJ; Sullenberger C; Edwards P; Roncal NE; Mensa-Wilmot K; Pollastri MP
    J Med Chem; 2013 May; 56(10):3820-32. PubMed ID: 23597080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro.
    Ferrigno F; Biancofiore I; Malancona S; Ponzi S; Paonessa G; Graziani R; Bresciani A; Gennari N; Di Marco A; Kaiser M; Summa V; Harper S; Ontoria JM
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3689-3692. PubMed ID: 30482621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
    Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
    Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and development of the 1,4-benzodiazepin-2-one and quinazoline-2,4-dione scaffolds as submicromolar inhibitors of HAT.
    Clark RL; Clements CJ; Barrett MP; Mackay SP; Rathnam RP; Owusu-Dapaah G; Spencer J; Huggan JK
    Bioorg Med Chem; 2012 Oct; 20(20):6019-33. PubMed ID: 22985960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 1,2-dihydroquinazolin-2-ones: Design, synthesis, and biological evaluation against Trypanosoma brucei.
    Pham T; Walden M; Butler C; Diaz-Gonzalez R; Pérez-Moreno G; Ceballos-Pérez G; Gomez-Pérez V; García-Hernández R; Zecca H; Krakoff E; Kopec B; Ichire O; Mackenzie C; Pitot M; Ruiz LM; Gamarro F; González-Pacanowska D; Navarro M; Dounay AB
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3629-3635. PubMed ID: 28729055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents.
    Yang PY; Wang M; Li L; Wu H; He CY; Yao SQ
    Chemistry; 2012 May; 18(21):6528-41. PubMed ID: 22488888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From Cells to Mice to Target: Characterization of NEU-1053 (SB-443342) and Its Analogues for Treatment of Human African Trypanosomiasis.
    Devine WG; Diaz-Gonzalez R; Ceballos-Perez G; Rojas D; Satoh T; Tear W; Ranade RM; Barros-Álvarez X; Hol WG; Buckner FS; Navarro M; Pollastri MP
    ACS Infect Dis; 2017 Mar; 3(3):225-236. PubMed ID: 28110521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hit-to-Lead Optimization of Benzoxazepinoindazoles As Human African Trypanosomiasis Therapeutics.
    Klug DM; Tschiegg L; Diaz R; Rojas-Barros D; Perez-Moreno G; Ceballos G; García-Hernández R; Martinez-Martinez MS; Manzano P; Ruiz LM; Caffrey CR; Gamarro F; Pacanowska DG; Ferrins L; Navarro M; Pollastri MP
    J Med Chem; 2020 Mar; 63(5):2527-2546. PubMed ID: 31670951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of halo-nitrobenzamides with potential application against human African trypanosomiasis.
    Hwang JY; Smithson D; Connelly M; Maier J; Zhu F; Guy KR
    Bioorg Med Chem Lett; 2010 Jan; 20(1):149-52. PubMed ID: 19963377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of Physicochemical Properties for 4-Anilinoquinoline Inhibitors of Plasmodium falciparum Proliferation.
    Mehta N; Ferrins L; Leed SE; Sciotti RJ; Pollastri MP
    ACS Infect Dis; 2018 Apr; 4(4):577-591. PubMed ID: 29301082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Indoline-2-carboxamide Derivatives as a New Class of Brain-Penetrant Inhibitors of Trypanosoma brucei.
    Cleghorn LA; Albrecht S; Stojanovski L; Simeons FR; Norval S; Kime R; Collie IT; De Rycker M; Campbell L; Hallyburton I; Frearson JA; Wyatt PG; Read KD; Gilbert IH
    J Med Chem; 2015 Oct; 58(19):7695-706. PubMed ID: 26418485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orally Active and Selective Tubulin Inhibitors as Anti-Trypanosome Agents.
    Nanavaty V; Lama R; Sandhu R; Zhong B; Kulman D; Bobba V; Zhao A; Li B; Su B
    PLoS One; 2016; 11(1):e0146289. PubMed ID: 26771307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lead Optimization of 3,5-Disubstituted-7-Azaindoles for the Treatment of Human African Trypanosomiasis.
    Klug DM; Mavrogiannaki EM; Forbes KC; Silva L; Diaz-Gonzalez R; Pérez-Moreno G; Ceballos-Pérez G; Garcia-Hernández R; Bosch-Navarrete C; Cordón-Obras C; Gómez-Liñán C; Saura A; Momper JD; Martinez-Martinez MS; Manzano P; Syed A; El-Sakkary N; Caffrey CR; Gamarro F; Ruiz-Perez LM; Gonzalez Pacanowska D; Ferrins L; Navarro M; Pollastri MP
    J Med Chem; 2021 Jul; 64(13):9404-9430. PubMed ID: 34156862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of trypanosome alternative oxidase without its N-terminal mitochondrial targeting signal (ΔMTS-TAO) by cationic and non-cationic 4-hydroxybenzoate and 4-alkoxybenzaldehyde derivatives active against T. brucei and T. congolense.
    Ebiloma GU; Ayuga TD; Balogun EO; Gil LA; Donachie A; Kaiser M; Herraiz T; Inaoka DK; Shiba T; Harada S; Kita K; de Koning HP; Dardonville C
    Eur J Med Chem; 2018 Apr; 150():385-402. PubMed ID: 29544150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel pyrrolobenzoxaboroles: design, synthesis, and biological evaluation against Trypanosoma brucei.
    Wu P; Zhang J; Meng Q; Nare B; Jacobs RT; Zhou H
    Eur J Med Chem; 2014 Jun; 81():59-75. PubMed ID: 24826816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. African trypanosomiasis: Synthesis & SAR enabling novel drug discovery of ubiquinol mimics for trypanosome alternative oxidase.
    West RA; O'Doherty OG; Askwith T; Atack J; Beswick P; Laverick J; Paradowski M; Pennicott LE; Rao SPS; Williams G; Ward SE
    Eur J Med Chem; 2017 Dec; 141():676-689. PubMed ID: 29107420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 9- and 11-Substituted 4-azapaullones are potent and selective inhibitors of African trypanosoma.
    Maiwald F; Benítez D; Charquero D; Dar MA; Erdmann H; Preu L; Koch O; Hölscher C; Loaëc N; Meijer L; Comini MA; Kunick C
    Eur J Med Chem; 2014 Aug; 83():274-83. PubMed ID: 24973661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bistacrines as potential antitrypanosomal agents.
    Schmidt I; Göllner S; Fuß A; Stich A; Kucharski A; Schirmeister T; Katzowitsch E; Bruhn H; Miliu A; Krauth-Siegel RL; Holzgrabe U
    Bioorg Med Chem; 2017 Aug; 25(16):4526-4531. PubMed ID: 28698054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of orally active anti-Trypanosoma agents.
    Salem FM; Martin WR; Zhao X; Adbus Sayeed SK; Ighneim S; Greene M; Mohamed E; Orahoske CM; Zhang W; Li B; Su B
    Bioorg Med Chem; 2024 Jun; 107():117751. PubMed ID: 38762979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.